FDA Inspection
VA GLA Health Care System (WLA) 113VA GLA Health Care System (WLA) 113 – FDA Inspection, Apr 1, 2016
Record Details
This FDA Inspection record concerns VA GLA Health Care System (WLA) 113, with an inspection on April 1, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 1, 2016
- Product Type
- Biologics
View Company Profile
ID · ca744472-8f5d-41a0-8182-7300a1710907
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 975123
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of VA GLA Health Care System (WLA) 113
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 10, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 9, 2023 | Not classified | Los Angeles District Office | |
| March 27, 2019 | Not classified | Los Angeles District Office | |
| September 24, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 22, 2017 | Not classified | Los Angeles District Office |
Other documents for VA GLA Health Care System (WLA) 113
- FDA Inspection 1332600 - 2026-08-10
- FDA Inspection 1205769 - 2023-05-09
- FDA Inspection 1085423 - 2019-03-27
- FDA Inspection 1069120 - 2018-09-24
- FDA Inspection 1005291 - 2017-03-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.